Showing 15,921 - 15,940 results of 26,842 for search '(( 50 ((ppm decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 1.09s Refine Results
  1. 15921

    <b>Single-dose replicon RNA Sudan virus vaccine uniformly protects female guinea pigs from disease</b> by Andrea Marzi (758337)

    Published 2025
    “…There are currently no licensed countermeasures against SUDV. We developed a SUDV vaccine candidate based on a nanocarrier (LION<sup>TM</sup>) complexed with an alphavirus-based replicon RNA. …”
  2. 15922

    Analysis of Chimpanzee History Based on Genome Sequence Alignments by Jennifer L. Caswell (89812)

    Published 2008
    “…We infer that the central chimpanzee population size increased by at least a factor of 4 since its separation from western chimpanzees, while the western chimpanzee effective population size decreased. …”
  3. 15923

    Image1_Ethyl 2-Succinate-Anthraquinone Attenuates Inflammatory Response and Oxidative Stress via Regulating NLRP3 Signaling Pathway.TIF by Burong Feng (11661529)

    Published 2021
    “…In vivo, we revealed that the LHD, in different doses (6.25 mg/kg, 12.5 mg/kg, 25 mg/kg, 50 mg/kg), has a protective effect on stress physiological responses by assessing the body temperature of mice. …”
  4. 15924
  5. 15925
  6. 15926

    Image2_Ethyl 2-Succinate-Anthraquinone Attenuates Inflammatory Response and Oxidative Stress via Regulating NLRP3 Signaling Pathway.TIF by Burong Feng (11661529)

    Published 2021
    “…In vivo, we revealed that the LHD, in different doses (6.25 mg/kg, 12.5 mg/kg, 25 mg/kg, 50 mg/kg), has a protective effect on stress physiological responses by assessing the body temperature of mice. …”
  7. 15927
  8. 15928
  9. 15929

    Image_4_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  10. 15930

    Image_6_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  11. 15931

    Data_Sheet_1_Seed Dormancy and Soil Seed Bank of the Two Alpine Primula Species in the Hengduan Mountains of Southwest China.DOCX by De-Li Peng (3204021)

    Published 2021
    “…Cold stratification released PD completely after dry storage, increasing final germination, and widening the temperature range from medium to both high and low; moreover, the T<sub>b</sub> and θ<sub>50</sub> for germination decreased. Fresh seeds had a light requirement for germination, facilitating formation of a persistent soil seed bank. …”
  12. 15932

    Image_5_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  13. 15933
  14. 15934
  15. 15935

    Secondary screening and ‘hit’ validation. by Ilona Tkachyova (343715)

    Published 2016
    “…Distinct decrease in <i>NDST1</i> expression was observed for 2x IC<sub>50</sub> SAHA treatment. …”
  16. 15936
  17. 15937
  18. 15938
  19. 15939
  20. 15940